Abstract
Ochratoxin A (OA), a dihydroisocoumarin containing mycotoxin, is a widespread natural contaminant of a variety of food and feedstuffs at levels ranging from 9–27500 ug/kg (1). Ingestion of OA has been shown to induce nephropathy in several species (1) while dietary feeding induced renal adenomas and hepatocellular carcinomas in mice (2). OA did not produce genetic or related effects in a variety of in vitro, short termtests, but it has been shown to induce single strand breaks in DNA of liver, kidney and spleen (3). OA is suspected of being the main aetiologic agent responsible for Balkan endemic nephropathy (BEN) and associated urinary tract tumours, diseases which affect multiple members of families residing in restricted areas of Bulgaria, Yugoslavia and Romania (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
P. Krogh & S. Nesheim. Ochratoxin A, In “Environmental Carcinogens — Selected Methods of Analysis, Vol. 5: Some Mycotoxins”. Stoloff, L., Castegnaro, M., Scott, P., O’Neill, I.K. & Bartsch, H., eds, IARC Scientific Publications No. 44, International Agency for Research on Cancer, Lyon (1982).
A.M. Bendele, W.W. Carlton, P. Krogh and E.B. Lillehoj. Ochratoxin A Carcinogenesis in B6C3F1 Mouse. J. Natl. Cancer Inst., 375:733 (1985).
E.E. Creppy, A. Kane, G. Dirheimer, C. Lafarge-Frayssinet, S Mousset and C. Frayssinet. Genotoxicity of Ochratoxin A in Mice: DNA singlestrand break evaluation in spleen, liver and kidney. Toxicol. Lett., 28:29 (1985)
E. Hietanen, C. Malaveille, A.-M. Camus, J.-C. Bereziat, G. Brun, M. Castegnaro, J. Michelon, J.R. Idle and H. Bartsch. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9mediated mutagenicity in OA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drug Metab. Dispos., 14:118 (1986).
E. Hietanen, H. Bartsch, M. Castegnaro, C. Malaveille, J. Michelon and L. Broussolle. Use of antibodies (Ab) against cytochrome P-450 isozymes to study genetic polymorphism in drug oxidations. J. Pharm. Clin., 4:71 (1985).
J.C. Ritchie, M.J. Crothers, L.R. Idle, J.B. Crieg, T.A. Connors, I.G. Nikolov and I.N. Chernozemsky. Evidence for an inherited metabolic susceptibility to endemic (Balkan) nephropathy. In: “Proceedings of the 5th Symposium on Endemic Balkan Nephropathy”, S. Strahinie and V. Stefanovic, eds. p. 23 (1983).
M. Castegnaro, I.N. Chernozemsky and H. Bartsch. Meeting Report: Endemic Nephropathy and Urinary Tract Tumors in the Balkans. Cancer Res., (1987) (in press).
S.G. Dabbagh, J.R. Idle and R.L. Smith. Animal modelling of human polymorphic drug oxidation, the metabolism of debrisoquine and phenacetin in rat inbread strains. J. Pharmacol. , 33:161 (1981).
A.D. Rahimtula, J.-C. Bereziat, V. Bussachini-Griot and H. Bartsch. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol., (submitted for publication).
Z.A. Shamsuddin and A.D. Rahimtula. Metabolic activation of 2,6dimethyl-naphthalene by liver microsomes and effect on tissue glutathione levels in vivo. Drug Metab. Dispos., 14:724 (1986).
P.R. Miles, J.R. Wright, L. Bowman and H.D. Colby. Inhibition of hepatic microsomal lipid peroxidation by drug substrate without drug metabolism. Biochem. Pharmacol., 29:565 (1980).
F.C. Stormer, C.E. Hansen, J.I. Pedersen, G. Hvistendahl and A.J. Aasen. Formation of (4R) and (4S)-4-hydroxyochratoxin A from ochratoxin A by liver microsomes from various species. Appl. Environ. Microbiol., 42:1051 (1981).
F.S. Chu. Interaction of ochratoxin A with bovine serum albumin. Biochem. Biophvs., 147:359 (1971).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rahimtula, A.D. et al. (1989). Lipid Peroxidation as a Possible Cause of Ochratoxin a Toxicity. In: Bach, P.H., Lock, E.A. (eds) Nephrotoxicity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2040-2_95
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2040-2_95
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2042-6
Online ISBN: 978-1-4757-2040-2
eBook Packages: Springer Book Archive